NewGenIvf Group Ltd

NewGenIvf Group Limited operates as an investment holding company providing assisted reproductive services across Southeast Asia and Central Asia. Founded in 2010 and headquartered in Bangkok, the company delivers a comprehensive range of fertility treatments including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), embryo culture, chromosome screening, and egg freezing. The company also offers diagnostic services such as hormonal blood tests, infectious disease screening, and sperm analysis with processing capabilities including sorting, washing, and freezing.

Beyond core fertility treatments, NewGenIvf provides surrogacy services alongside ancillary care for surrogate mothers, encompassing regular health check-ups and pharmaceutical support. The company supplements its clinical offerings with value-added services including nutrition guidance, psychological counselling, acupuncture, and translation services to support patient treatment outcomes. Services are delivered through owned clinic facilities.

The company maintains a physical presence in Thailand, Cambodia, Hong Kong, and Kyrgyzstan, serving patients across multiple markets in the region. NewGenIvf operates with a workforce of 76 full-time employees. The company is incorporated in the British Virgin Islands and listed on Nasdaq.